|
|
12 Health Care Stocks Moving In Friday's Intraday Session
|
|
|
|
This Codere Online Luxembourg Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday
|
|
|
|
Citizens Downgrades Quince Therapeutics to Market Perform
|
|
|
|
Quince Therapeutics Stock Collapses After Key Trial Update In Rare Genetic Disease
|
|
|
|
D. Boral Capital Downgrades Quince Therapeutics to Hold
|
|
|
|
12 Health Care Stocks Moving In Thursday's After-Market Session
|
|
|
|
Quince Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Down -92.45%
|
|
|
|
Quince Therapeutics shares are trading lower after the company reported that its Phase 3 NEAT clinical study of dexamethasone sodium phosphate encapsulated in autologous erythrocytes failed to meet statistical significance and key secondary endpoint of improvement in Clinical Global Impression of Severity.
|
|
|
|
Quince Therapeutics Shares Resume Trading
|
|
|
|
Quince Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Down -87.74%
|
|